Navigation Links
BioDuro & The National Center for Safety Evaluation of Drugs Received Full AAALAC Accreditation
Date:4/18/2008

BEIJING, April 18 /PRNewswire/ -- BioDuro & The National Center for Safety Evaluation of Drugs (NCSED, the "Center") in Beijing announce their receipt of full AAALAC accreditation. BioDuro and the Center collaborate to offer preclinical toxicology and large animal DMPK for clients worldwide.

Dean Rodwell, BioDuro's Vice-President of Toxicology stated "Although we have been operating under this standard for over a year, it is exciting to receive this important, internationally recognized official accreditation. BioDuro is now working closely with the Center to attain US FDA GLP certification and expects to be operating at this level by the third quarter of 2008."

Dr. Li Bo from the National Institute for the Control of Pharmaceutical and Biological Product (NICPBP) mentioned "AAALAC accreditation is a wonderful step as we expand our exceptional services."

The Center's main tasks are to carry out the toxicological tests and preclinical safety evaluation of drugs in the field of non-clinical research and development. It possesses experienced scientific and technical teams in disciplines such as pharmacology, toxicology, laboratory animal services, analytical chemistry, biochemistry, physiology and pathology. It is well equipped with instrumentation and animal facilities and is strictly managed according to Chinese GLP. The Center is currently engaged in toxicological tests and preclinical safety evaluation of drugs, on the basis of drug registration requirements of both domestic and international regulations.

BioDuro is a US-based, fully-integrated, global life science outsourcing services company, committed to creating high-quality, integrated R&D capabilities in China to meet the growing needs of the global biotechnology and pharmaceutical industries. Our functional strengths are in medicinal chemistry, synthetic chemistry, biology, assay development/screening, DMPK and toxicology. We have hired exceptional, experienced people in each discipline from around the world. We have placed a premium on drug discovery experience in the West and have many scientists with such experience. We have built world-class laboratories for each function in Beijing and have unique access to toxicology and large animal DMPK via our collaboration with the Center. Our customers are over 40 pharmaceutical and biotechnology companies including 9 of the top 12 global pharmaceutical companies. Unlike many others, BioDuro's leadership team is built with true expertise across all aspects of drug discovery and a deep understanding of how to build and operate a high quality professional services organization.

For more information on the services offered by BioDuro and The National Center for Safety Evaluation of Drugs please contact BioDuro at 4350 La Jolla Village Drive, Suite 450, San Diego, CA 92121, 1-888-251-1697, info@bioduro.com or visit our website at http://www.bioduro.com.


'/>"/>
SOURCE BioDuro
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
4. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
5. The Government of Quebec and the New Canadian Government Invest in the Creation of an International Biobank
6. International Isotopes Inc. Announces Completion of an Exclusive Distributor Agreement for Sales of New Style Transportation Containers
7. Arrow International Files and Mails Definitive Proxy Materials
8. Niceware International Announces Licensed Vendor Status with ICCBBA, Inc. to Provide ISBT 128-compliant Software
9. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
10. Viragen International to Reverse Split Its Common Stock
11. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is pleased to announce the launch of their brand, UP4™ Probiotics, into Target ... over 35 years, is proud to add Target to its list of well-respected ...
(Date:6/23/2016)... 2016 Houston Methodist Willowbrook Hospital has ... Association to serve as their official health care ... Willowbrook will provide sponsorship support, athletic training services, ... coaches, volunteers, athletes and families. "We ... Association and to bring Houston Methodist quality services ...
(Date:6/23/2016)... FRANCISCO , June 23, 2016   EpiBiome ... has secured $1 million in debt financing from Silicon ... ramp up automation and to advance its drug development ... its new facility. "SVB has been an ... beyond the services a traditional bank would provide," said ...
Breaking Biology Technology:
(Date:6/1/2016)... NEW YORK , June 1, 2016 ... Biometric Technology in Election Administration and Criminal Identification to ... According to a recently released TechSci Research report, " ... Sector, By Region, Competition Forecast and Opportunities, 2011 - ... $ 24.8 billion by 2021, on account of growing ...
(Date:5/9/2016)... , UAE, May 9, 2016 ... it comes to expanding freedom for high net worth ... Even in today,s globally connected world, there is still ... system could ever duplicate sealing your deal with a ... second passports by taking advantage of citizenship via investment ...
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
Breaking Biology News(10 mins):